Financing shortfall due to unexercised stock acquisition rights
First written in FY2019-Q3. 2 of 5 entries say "Restated". Latest entry: FY2020-Q3.
Demae-Can moved to the "Worse" side of this theme in 2020.
1 other company's latest entry also says "Materialised".
- FY2020-Q3MaterialisedAnnual report
「No disclosure was made because the stock acquisition rights with an exercise price adjustment clause had not been exercised.」
The Series 11 stock acquisition rights remained unexercised, and the remaining rights were acquired and cancelled, confirming that funding through these rights would not progress. - FY2020-Q2MaterialisedAnnual report
「Although stock acquisition rights with an exercise price adjustment clause remained outstanding, they were not exercised, so no disclosure was made.」
As the Series 11 stock acquisition rights continued to remain unexercised and the remaining rights were scheduled to be acquired and cancelled, the lack of progress in raising funds through these rights became more concrete. - FY2020-Q1RestatedAnnual report
「Although stock acquisition rights with an exercise price adjustment clause remained outstanding, they were not exercised, so no disclosure was made.」
The company disclosed that stock acquisition rights remained outstanding but had not been exercised during the quarter. - FY2019RestatedAnnual report
「If no funds are raised through the exercise of these stock acquisition rights, the amount raised may fall below our expectations. In addition, because a cash payment equal to the issue price of these stock acquisition rights may be required, the final amount raised through them may decrease.」
The risk that the amount raised would fall below expectations due to the continued non-exercise of the Series 11 stock acquisition rights and purchase requests continues to be disclosed. - FY2019-Q3First statedAnnual report
「If no funds are raised through the exercise of these stock acquisition rights, the amount raised may fall below our expectations. In addition, because a cash payment equal to the issue price of these stock acquisition rights may be required, the final amount raised through them may decrease.」
For the Series 11 stock acquisition rights, the company newly disclosed the risk that expected funding might not be achieved if the allottee requested the company to purchase the rights due to a decline in the share price, lower trading volume or rights remaining unexercised before the end of the exercise period.